AMARIN CORP PLC\UK Inventory, Finished Goods, Gross
AMARIN CORP PLC\UK (AMRN) had Inventory, Finished Goods, Gross of $39.95 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryFinishedGoods · last filed 2026-07-29
- 2026-06-30: Inventory, Finished Goods, Gross $39.95M.
- 2026-03-31: Inventory, Finished Goods, Gross $55.47M.
- 2025-12-31: Inventory, Finished Goods, Gross $75.42M.
- 2025-09-30: Inventory, Finished Goods, Gross $88.44M.
| Period end | Inventory, Finished Goods, Gross |
|---|---|
| 2026-06-30 | $39.95M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $55.47M 10-Q · filed 2026-04-29 |
| 2025-12-31 | $75.42M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $88.44M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $95.25M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $104.14M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $108.89M 10-K · filed 2026-03-02 |
| 2024-09-30 | $120.58M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $134.44M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $154.20M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $175.73M 10-K · filed 2025-03-12 |
| 2023-09-30 | $199.34M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $220.69M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $235.43M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $213.66M 10-K · filed 2024-02-29 |
| 2022-09-30 | $227.63M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $240.31M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $229.34M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $206.27M 10-K · filed 2023-03-01 |
| 2021-09-30 | $197.91M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $157.08M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $125.33M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $107.82M 10-K · filed 2022-03-01 |
| 2020-09-30 | $92.19M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $65.67M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $51.34M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $45.28M 10-K · filed 2021-02-25 |
| 2019-09-30 | $28.03M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $36.01M 10-Q · filed 2019-07-31 |
| 2019-03-31 | $41.47M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $35.36M 10-K · filed 2020-02-25 |
| 2018-09-30 | $23.66M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $19.59M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $17.08M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $12.37M 10-K · filed 2019-02-27 |
| 2012-12-31 | $326.00K 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |